Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor

Assignee

• Abb Vie Deutschland
• Abb Vie

Inventors

• Andreas Haupt (70 patents)
• Jurgen Dinges (29 patents)
• Liliane Unger (125 patents)
• Karsten Wicke (32 patents)
• Robert Van Waterschoot (3 patents)
• Scott Mittelstadt (1 patents)
• Karla Drescher (52 patents)
• Ana-Lucia Relo (23 patents)

View full patent text on Google Patents →